These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9181567)

  • 21. A possible nonimmunologic biological response to neoplasia: the tumor fibrovascular stroma.
    Machado EA
    J Biol Response Mod; 1985 Feb; 4(1):3-7. PubMed ID: 2580062
    [No Abstract]   [Full Text] [Related]  

  • 22. [principal characteristics of tumor microcirculation revealed by experimental techniques in vivo].
    Vicaut E
    Therapie; 2001; 56(5):483-94. PubMed ID: 11806284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.
    Horsman MR; Siemann DW
    Cancer Res; 2006 Dec; 66(24):11520-39. PubMed ID: 17178843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration.
    Legg JA; Herbert JM; Clissold P; Bicknell R
    Angiogenesis; 2008; 11(1):13-21. PubMed ID: 18264786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lattice and non-lattice models of tumour angiogenesis.
    Plank MJ; Sleeman BD
    Bull Math Biol; 2004 Nov; 66(6):1785-819. PubMed ID: 15522355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668.
    Davis DW; Takamori R; Raut CP; Xiong HQ; Herbst RS; Stadler WM; Heymach JV; Demetri GD; Rashid A; Shen Y; Wen S; Abbruzzese JL; McConkey DJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):678-89. PubMed ID: 15701856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial cell development, vasculogenesis, angiogenesis, and tumor neovascularization: an update.
    Tang DG; Conti CJ
    Semin Thromb Hemost; 2004 Feb; 30(1):109-17. PubMed ID: 15034802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Order and disorder in the vascular network.
    Guidolin D; Nico B; Mazzocchi G; Vacca A; Nussdorfer GG; Ribatti D
    Leukemia; 2004 Nov; 18(11):1745-50. PubMed ID: 15505617
    [No Abstract]   [Full Text] [Related]  

  • 29. [Targeting angiogenesis in oncology].
    Fayette J; Soria JC; Armand JP
    Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1992 Mack Forster Award Lecture. Review. Regulation of angiogenesis in vitro.
    Montesano R
    Eur J Clin Invest; 1992 Aug; 22(8):504-15. PubMed ID: 1385149
    [No Abstract]   [Full Text] [Related]  

  • 31. Coupled modeling of blood perfusion in intravascular, interstitial spaces in tumor microvasculature.
    Wu J; Xu S; Long Q; Collins MW; König CS; Zhao G; Jiang Y; Padhani AR
    J Biomech; 2008; 41(5):996-1004. PubMed ID: 18222455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of mechanical host-tumour interactions in the collapse of tumour blood vessels and tumour growth dynamics.
    Araujo RP; McElwain DL
    J Theor Biol; 2006 Feb; 238(4):817-27. PubMed ID: 16384586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization.
    Shin D; Garcia-Cardena G; Hayashi S; Gerety S; Asahara T; Stavrakis G; Isner J; Folkman J; Gimbrone MA; Anderson DJ
    Dev Biol; 2001 Feb; 230(2):139-50. PubMed ID: 11161568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenesis and inflammation face off.
    Imhof BA; Aurrand-Lions M
    Nat Med; 2006 Feb; 12(2):171-2. PubMed ID: 16462798
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeting tumor vasculature with homing peptides from phage display.
    Ruoslahti E
    Semin Cancer Biol; 2000 Dec; 10(6):435-42. PubMed ID: 11170865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On target with tumor blood vessel markers.
    Zetter BR
    Nat Biotechnol; 1997 Nov; 15(12):1243-4. PubMed ID: 9359101
    [No Abstract]   [Full Text] [Related]  

  • 37. [Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].
    Werther K; Nielsen HJ
    Ugeskr Laeger; 2000 Sep; 162(37):4916-20. PubMed ID: 11002739
    [No Abstract]   [Full Text] [Related]  

  • 38. Tumor-vascular interactions and tumor dormancy.
    Naumov GN; Folkman J; Straume O; Akslen LA
    APMIS; 2008; 116(7-8):569-85. PubMed ID: 18834403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. REVIEW: the integrin alpha V beta 3: angiogenesis and apoptosis.
    Varner JA; Brooks PC; Cheresh DA
    Cell Adhes Commun; 1995 Nov; 3(4):367-74. PubMed ID: 8821037
    [No Abstract]   [Full Text] [Related]  

  • 40. Different patterns of angiogenesis in sarcomas and carcinomas.
    Tomlinson J; Barsky SH; Nelson S; Singer S; Pezeshki B; Lee MC; Eilber F; Nguyen M
    Clin Cancer Res; 1999 Nov; 5(11):3516-22. PubMed ID: 10589766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.